scholarly article | Q13442814 |
P2093 | author name string | Yu-Chen Hu | |
Yiu-Kay Lai | |||
Hung-Jen Liu | |||
Yao-Chi Chung | |||
Chia-Wei Lai | |||
Ding-Gang Yang | |||
P2860 | cites work | Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo | Q45422816 |
Baculovirus as a highly efficient gene delivery vector for the expression of hepatitis delta virus antigens in mammalian cells | Q45532831 | ||
Determination of the baculovirus transducing titer in mammalian cells | Q45888110 | ||
Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response | Q47773636 | ||
Baculovirus-mediated gene expression in chicken primary cells. | Q50733500 | ||
Characterization of cell-surface determinants important for baculovirus infection. | Q52585258 | ||
Altering the surface properties of baculovirus Autographa californica NPV by insertional mutagenesis of the envelope protein gp64. | Q52599079 | ||
Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine | Q73593910 | ||
Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza | Q80422025 | ||
Baculovirus entry into human hepatoma cells | Q24534731 | ||
Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion | Q27863777 | ||
Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutinin | Q28646303 | ||
Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic. | Q30322954 | ||
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. | Q30327772 | ||
Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. | Q30341146 | ||
Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. | Q30351356 | ||
Baculoviral display of the green fluorescent protein and rubella virus envelope proteins. | Q30428621 | ||
Non-polar distribution of green fluorescent protein on the surface of Autographa californica nucleopolyhedrovirus using a heterologous membrane anchor | Q31055145 | ||
Amino-terminal anchored surface display in insect cells and budded baculovirus using the amino-terminal end of neuraminidase | Q31118368 | ||
Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface. | Q32060361 | ||
Recombinant baculoviruses as expression vectors for insect and mammalian cells | Q33744882 | ||
Influenza virus genetics | Q33953751 | ||
Baculovirus as versatile vectors for protein expression in insect and mammalian cells | Q34416430 | ||
The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins | Q34553841 | ||
Budding of rabies virus particles in the absence of the spike glycoprotein | Q34662773 | ||
Location, sequence, transcriptional mapping, and temporal expression of the gp64 envelope glycoprotein gene of the Orgyia pseudotsugata multicapsid nuclear polyhedrosis virus | Q35845998 | ||
Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. | Q35887822 | ||
Baculovirus as a highly efficient expression vector in insect and mammalian cells. | Q36075878 | ||
Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain | Q36626279 | ||
Baculovirus vectors elicit antigen-specific immune responses in mice | Q36684637 | ||
Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment) | Q37590682 | ||
Baculovirus surface display: construction and screening of a eukaryotic epitope library | Q38337245 | ||
Palmitoylation of the Autographa californica multicapsid nucleopolyhedrovirus envelope glycoprotein GP64: mapping, functional studies, and lipid rafts | Q39752634 | ||
The GP64 envelope fusion protein is an essential baculovirus protein required for cell-to-cell transmission of infection | Q39875210 | ||
Dual expression of the HA protein of H5N2 avian influenza virus in a baculovirus system | Q40306206 | ||
Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry | Q40329154 | ||
Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection | Q40619739 | ||
Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feeding | Q40658538 | ||
Influenza viruses select ordered lipid domains during budding from the plasma membrane | Q40980312 | ||
Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus | Q41051042 | ||
Immunological properties of FMDV-gP64 fusion proteins expressed on SF9 cell and baculovirus surfaces. | Q42043174 | ||
Baculoviral display of functional scFv and synthetic IgG-binding domains. | Q42055956 | ||
Requirement for GP64 to drive efficient budding of Autographa californica multicapsid nucleopolyhedrovirus | Q42059198 | ||
Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses | Q42716737 | ||
P433 | issue | 5 | |
P921 | main subject | avian influenza | Q43987 |
P1104 | number of pages | 8 | |
P304 | page(s) | 989-996 | |
P577 | publication date | 2007-03-20 | |
P1433 | published in | Molecular Therapy | Q15762400 |
P1476 | title | Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential | |
P478 | volume | 15 |
Q35061504 | A baculovirus dual expression system-based vaccine confers complete protection against lethal challenge with H9N2 avian influenza virus in mice |
Q39096206 | A novel baculovirus vector shows efficient gene delivery of modified porcine reproductive and respiratory syndrome virus antigens and elicits specific immune response. |
Q59359064 | A secretary bi-cistronic baculovirus expression system with improved production of the HA1 protein of H6 influenza virus in insect cells and Spodoptera litura larvae |
Q42268317 | Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease |
Q30386196 | Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice |
Q56514706 | Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development |
Q37873083 | Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications |
Q45869596 | Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering |
Q36337148 | Baculovirus as a vaccine vector |
Q39649585 | Baculovirus as an avian influenza vaccine vector: Differential immune responses elicited by different vector forms |
Q43001874 | Baculovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models |
Q39949984 | Baculovirus surface display of E2 envelope glycoprotein of classical swine fever virus and immunogenicity of the displayed proteins in a mouse model |
Q39937129 | Baculovirus surface display of sigmaC and sigmaB proteins of avian reovirus and immunogenicity of the displayed proteins in a mouse model |
Q91783230 | Baculovirus surface display of the HA protein of H5N2 avian influenza virus and its immunogenicity against a lethal challenge with H5N1 virus in chickens |
Q37434539 | Baculovirus vector as a delivery vehicle for influenza vaccines |
Q57064366 | Baculovirus vector for gene delivery and vaccine development |
Q40880160 | Baculovirus vectors expressing F proteins in combination with virus-induced signaling adaptor (VISA) molecules confer protection against respiratory syncytial virus infection |
Q35897609 | Baculovirus-based Vaccine Displaying Respiratory Syncytial Virus Glycoprotein Induces Protective Immunity against RSV Infection without Vaccine-Enhanced Disease |
Q55383943 | CRISPR therapeutic tools for complex genetic disorders and cancer (Review). |
Q37980587 | Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks |
Q40039573 | Combination of baculovirus-expressed BMP-2 and rotating-shaft bioreactor culture synergistically enhances cartilage formation |
Q59358457 | Construction of a highly efficient display system for baculovirus and its application on multigene co-display |
Q57001380 | Display of Porcine Epidemic Diarrhea Virus Spike Protein on Baculovirus to Improve Immunogenicity and Protective Efficacy |
Q40055149 | Display of heterologous proteins on gp64null baculovirus virions and enhanced budding mediated by a vesicular stomatitis virus G-stem construct |
Q30427591 | Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses |
Q42062273 | Gene expression profiles in primary duodenal chick cells following transfection with avian influenza virus H5 DNA plasmid encapsulated in silver nanoparticles |
Q39665121 | Hemagglutinin Displayed Baculovirus Protects Against Highly Pathogenic Influenza |
Q39875287 | Hybrid of baculovirus and galactosylated PEI for efficient gene carrier |
Q43434704 | Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen |
Q33490614 | Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses |
Q37729202 | Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells |
Q37547066 | Innate immune response induced by baculovirus attenuates transgene expression in mammalian cells |
Q37909427 | Insect cell technology is a versatile and robust vaccine manufacturing platform |
Q39825058 | Localization of VP28 on the baculovirus envelope and its immunogenicity against white spot syndrome virus in Penaeus monodon |
Q92223350 | Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances |
Q34070469 | Oral vaccination of baculovirus-expressed VP28 displays enhanced protection against White Spot Syndrome Virus in Penaeus monodon |
Q30390108 | Particle and subunit-based hemagglutinin vaccines provide protective efficacy against H1N1 influenza in pigs |
Q39830488 | Production of scFv-displaying BmNPV in silkworm larvae and its efficient purification |
Q30374662 | Pseudotype-based neutralization assays for influenza: a systematic analysis. |
Q30373913 | Safety and immunogenicity of H5N1 influenza vaccine based on baculovirus surface display system of Bombyx mori |
Q30382226 | Strategies towards universal pandemic influenza vaccines. |
Q36235817 | Two Distinctive Phenotypes of AcMNPV Display Different Immune Abilities and Intracellular Destiny |
Q38243160 | Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens |
Q33396583 | WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine |